SuperworthSkye Bioscience market cap SKYE
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $6.8M
- Highest close in our data
- $452.9M
- Apr 2024
Skye Bioscience is worth $6.8M at the close on Oct 23, 2026, at $1.54 a share.
That is down 86% over the last year and down 77% over five years.
Its highest close in our data was $452.9M in Apr 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $6.8M | $6.8M | $32.4M | −73% |
| 2025 | $25.6M | $25.6M | $147.2M | −66% |
| 2024 | $74.6M | $28.7M | $452.9M | +122% |
| 2023 | $33.6M | $6.3M | $43.2M | +130% |
| 2022 | $14.6M | $10.4M | $28.3M | −41% |
| 2021 | $24.8M | $10.3M | $67M | +148% |
| 2020 | $10M | $7.5M | $27.7M | −59% |
| 2019 | $24.1M | $24.1M | $133.9M | −54% |
| 2018 | $52.1M | $5.6M | $70.3M | +1006% |
| 2017 | $4.7M | $4M | $9.7M | −25% |
| 2016 | $6.3M | $6.3M | $14.8M | −53% |
| 2015 | $13.5M | $9.8M | $124M | −89% |
| 2014 | $128M | $128M | $168M | n/a |
Against its peers
Companies in Healthcare nearest Skye Bioscience's size, closest first, today.
| Company | Market cap |
|---|---|
| SKYESkye Bioscience | $6.8M |
| NEPHNephros | $38.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| APTAlpha Pro Tech | $56.7M |
| SPROSpero Therapeutics | $64.6M |
| Peer median | $52.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Skye Bioscience
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.